We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Reckitt, Generics Makers Settle Mucinex Antitrust Case

Law360, Los Angeles (November 29, 2017, 10:15 PM EST) -- Reckitt Benckiser Inc. has reached a settlement with a generic-drug maker that had accused the British company of unfairly cutting out competition for an extended-release version of Mucinex by violating a patent infringement settlement agreement they’d struck, according to a judgment Tuesday ending the Pennsylvania federal court case.

Reckitt resolved a two-year dispute with Mutual Pharmaceuticals Co. and related companies over whether Reckitt violated a 2007 settlement agreement in a patent suit over the formula that backs Mucinex, called extended-release guaifenesin, after nearly a year of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.